In a positive and delicious way, that is... In an effort to extend the reach of its regulatory compliance and document management offerings, Open Text (news, site) has partnered with Lionbridge (news, site) to provide joint customers with development services of the aforementioned solutions.
Led by Lionbridge, the alliance is specifically targeting the pharma industry, but it seems that other industries can take advantage of it as well.
Bringing Regulatory Compliance to the Pharmaceutical Industry
Lionbridge is best known for its translation and globalization, as well as development services. We all know Open Text as an ECM behemoth. Together, they plan to “streamline the development, implementation and integration of regulatory compliance solutions” and to deploy and integrate with content management solutions.
The two players will plan, design and implement compliance solutions for global pharmaceutical companies. The plan is also to integrate various other applications, as needed.
"Pharmaceutical companies and other organizations need a complete, reliable solution for managing enterprise content within a complex regulatory compliance environment," said Therese Harris, program manager for Life Sciences at Open Text.
Aligning in the Alliance
The program follows a very typical scenario and is designed to bring together vendors, systems integrators and other technology and service providers. There are quite a few content management vendors that currently do integration work with Lionbridge.
Remember we told you about Lionbridge’s Freeway -- a free, hosted translation management platform?
Freeway can connect to various CMSs via Web Services, thus providing a way for customers to improve processes and potentially lower the cost of global content management. One of the real perks is the ability to embed translation workflow into a CMS.
With Lionbridge’s access to its global clientele, many CMS vendors can certainly benefit from such an alliance. Open Text, on the other hand, has presence in 114 countries, and this sounds like a great opportunity to increase their international market share.
Coincidentally, the pharmaceutical industry is one of the industries experiencing growth despite the financial challenges.
Could this “marriage” be any better? Only customers will tell.